LONDON, April 19,
2024 /PRNewswire/ -- Prescient Healthcare
Group, a leading biopharma product and portfolio strategy firm,
has announced the appointment of two new members to its Board of
Directors – Dr. Luke Solon and
Debbie Allman – to help shape and
drive Prescient's global mission.
Dr. Luke Solon joined us in 2021
and leads our global medical practice. He earned his medical degree
from the University of Southampton and then spent four years as a
practicing physician, predominantly in general surgery. He has over
20 years of healthcare, consulting and pharmaceutical industry
experience, having started his consulting career at McKinsey &
Company and subsequently holding senior roles at AstraZeneca and
KPMG; immediately prior to joining Prescient, he was part of the
leadership team for the Life Sciences practice at Strategy& in
London. He has extensive
experience across multiple therapy areas and across the asset
lifecycle. At Prescient, he primarily works with our Medical
Affairs clients or on commercial engagements when a more clinical
lens is required. Still a clinician at heart, he is passionate
about supporting clients so their pharmaceutical innovations offer
maximum benefit to their patients.
Debbie Allman leads our global
Commercial practice, focusing in particular on driving our growth
in the US further. She is an accomplished commercial strategist
with a broad range of experience in pharmaceutical
commercialization and marketing. She started her career at
AstraZeneca, holding numerous global and national (UK, Italy) marketing and sales roles over a
15-year period; in 2010, she began her consulting career by
co-founding Strategic North, an insight-led brand strategy
consultancy firm that was acquired by Prescient in February 2022. Today, Debbie applies her
commercial strategy expertise and experience in new product
planning and brand building to work with clients at both large
pharmaceutical companies and mid-size pharma and biotech firms. She
is passionate about ensuring that the voice of the customer plays a
central role in strategic decision making, with the aim of
driving sustainable brand growth.
"We are pleased to welcome two exceptional leaders to the
Board," said Dr. Debasish Talukdar, CEO. "We are
strengthened by Luke and Debbie's expertise and experience serving
the pharmaceutical industry. They will bring diverse perspectives
to add depth and breadth to our Board."
"I am very pleased to welcome these new directors to the
Board," said Dr. Nicholas Edwards, Chairman. "They
bring experience, expertise and strong independent voices and will
help us better serve global biopharmaceutical companies and
accelerate our growth."
Contact information for Prescient can be found
at https://prescienthg.com/#contact.
About Prescient
We are Prescient
We are a specialist strategic partner to global biopharma
companies, with the expertise and experience to bring value across
the full drug lifecycle, from the preclinical stages to loss of
exclusivity and beyond. We partner with leading global
biopharmaceutical companies, fast-growing mid-caps and cutting-edge
emerging biotechs to unlock the full potential of their innovation
and significantly improve people's lives around the world.
Founded in 2007, we have developed into a highly diverse global
business with a footprint across three continents. This diversity
is our strength. Our team of over 500 people is spread across
thriving global hubs such as Boston, New
Delhi, London, Beijing, Munich and Barcelona, providing truly integrated global
perspectives that allow us to see further and go deeper.
We build from a foundation of scientific knowledge and deep
insights into molecules, markets and customers. This intersection
and the application of market, competitor and customer perspectives
is the foundation upon which our rigorous strategic thinking
thrives.
Prescient has been a portfolio company of Bridgepoint
Development Capital since 2021 and Baird Capital since 2017. For
more information, please visit: www.prescienthg.com.
Media Contact:
Michael White
+447528949905
376412@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/prescient-healthcare-group-appoints-two-new-members-to-its-board-of-directors-302121445.html
SOURCE Prescient Healthcare Group Ltd.